首页> 中文期刊> 《国际肝胆胰疾病杂志(英文版)》 >TraditionalChinesemedicineKangXian Fu FangⅠis effective for prophylaxis and treatmentofalcoholicliverdiseaseinrats

TraditionalChinesemedicineKangXian Fu FangⅠis effective for prophylaxis and treatmentofalcoholicliverdiseaseinrats

         

摘要

BACKGROUND:Reversal of liver ifbrosis is one of the key steps in the prevention and treatment of alcoholic liver disease (ALD), but the mechanism is unknown. This study was to investigate the effects of the Chinese medicine Kang Xian Fu Fang Ⅰ (KXⅠ) on prophylaxis and treatment of ALD in rats and its possible mechanism of action. METHODS: Eighty male Wistar rats were randomly divided into four groups: normal control; ALD model;treatment of ALD with KXⅠ; and prophylaxis of ALD by KXⅠ. At the end of 4, 8, 12 and 16 weeks, ifve rats from each group were anesthetized and their livers were removed for pathological studies using hematoxylin-eosin and Masson stain, immunohistochemical studies, and lfow cytometry for matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). Blood samples were taken for hyaluronic acid (HA) assay. RESULTS: Serum HA level and liver collagen content were lower in the groups given KXⅠfor prophylaxis and treatment than in ALD model group (P<0.05). The levels of MMP-2 and MMP-9 were also decreased in the prophylaxis and treatment groups (P<0.05). Immunohistochemistry showed immunoreactive MMP-2 in endothelial cells of the hepatic artery and portal vein, sinusoidal endothelial cells, and sinusoidal cells. Immunoreactive MMP-9 occurred in the hepatic cells around the veins and sinusoidal cells. CONCLUSIONS:KXⅠcan effectively inhibit or reverse the course of ALD. This may be attributable to its capacity to inhibit the expression of MMP-2 and MMP-9.

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2007年第002期|182-187|共6页
  • 作者单位

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

    Department of Gastroenterology Lv XH, Liu DP, Wang Y, Wang BY, Fu BY and Liu CR, Department of Laboratory Diagnosis Zhou LR, and Department of Pathology Song M, First Afifliated Hospital, China Medical University, Shenyang 110001, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号